 <h1>Alfentanil Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to alfentanil: intravenous solution</i></p><h3>Warning</h3><p class="blackboxWarning-title">Intravenous route (Solution)</p><p>Alfentanil HCl injection exposes users to risks of addiction, abuse, and misuse, which can lead to overdose and death. Assess patientâ€™s risk before prescribing and monitor regularly for these behaviors and conditions.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, alfentanil may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<i>Check with your doctor or nurse immediately</i> if any of the following side effects occur while taking alfentanil:</p><p>
<i>More common</i>
</p><ul>
<li>Blurred vision</li>
<li>chest pain or discomfort</li>
<li>confusion</li>
<li>difficult or troubled breathing</li>
<li>dizziness</li>
<li>dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position</li>
<li>fainting</li>
<li>fast, slow, pounding, or irregular heartbeat or pulse</li>
<li>headache</li>
<li>irregular, fast or slow, or shallow breathing</li>
<li>lightheadedness, dizziness, or fainting</li>
<li>nervousness</li>
<li>not breathing</li>
<li>pale or blue lips, fingernails, or skin</li>
<li>pounding in the ears</li>
<li>sweating</li>
<li>trouble breathing</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Cough</li>
<li>noisy breathing</li>
<li>rigid muscles of the neck, arms, and legs</li>
<li>tightness in the chest</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Agitation</li>
<li>cough</li>
<li>darkening of the skin</li>
<li>diarrhea</li>
<li>difficulty with swallowing</li>
<li>fainting</li>
<li>fever</li>
<li>hives, itching, or skin rash</li>
<li>loss of appetite</li>
<li>nausea</li>
<li>overactive reflexes</li>
<li>poor coordination</li>
<li>puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue</li>
<li>restlessness</li>
<li>shivering</li>
<li>sweating</li>
<li>talking or acting with excitement you cannot control</li>
<li>trembling or shaking</li>
<li>twitching</li>
<li>vomiting</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of alfentanil may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Drowsiness</li>
<li>sleepiness</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>False or unusual sense of well-being</li>
</ul><p>
<!-- end intravenous solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to alfentanil: injectable solution</i></p><h3>General</h3><p>The most commonly reported adverse reactions include apnea, rigidity, and bradycardia.<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Apnea</p>
<p><b>Uncommon</b> (0.1% to 1%): Hypercarbia, laryngospasm</p>
<p><b>Frequency not reported</b>: Life-threatening respiratory depression, postoperative respiratory depression, bronchospasm, hypoxia, bradypnea, hiccups, hypercapnia, epistaxis, airway complication of anesthesia, endotracheal intubation complication </p>
<p><b>Postmarketing reports</b>: Respiratory arrest, cough<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Postmarketing reports</b>: Anaphylaxis<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Arrhythmia, bradycardia (14%), hypertension (18%), hypotension (18%), tachycardia (12%) </p>
<p><b>Frequency not reported</b>: Asystole</p>
<p><b>Postmarketing reports</b>: Cardiac arrest<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Chest wall rigidity (17%), </p>
<p><b>Common</b> (1% to 10%): Skeletal muscle movements, muscle rigidity</p>
<p><b>Uncommon</b> (0.1% to 1%): Skeletal muscle rigidity of neck and extremities<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Dizziness, movement disorders, dyskinesia</p>
<p><b>Uncommon</b> (0.1% to 1%): Headache</p>
<p><b>Frequency not reported</b>: Serotonin syndrome, seizures, sleepiness/postoperative sedation, somnolence, neurological anesthetic complication </p>
<p><b>Postmarketing reports</b>: Myoclonic movements<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Euphoric mood</p>
<p><b>Uncommon</b> (0.1% to 1%): Postoperative confusion, postoperative euphoria, excitation</p>
<p><b>Frequency not reported</b>: Addiction abuse, misuse, agitation, crying</p>
<p><b>Postmarketing reports</b>: Disorientation<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (28%), vomiting (18%)<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Itching, urticaria</p>
<p><b>Frequency not reported</b>: Pruritus, allergic dermatitis, hyperhidrosis</p>
<p><b>Postmarketing reports</b>: Erythema, rash<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Injection site pain<sup>[Ref]</sup></p><h3>Endocrine</h3><p>Opioids: </p>
<p><b>Postmarketing reports</b>: Adrenal insufficiency, androgen deficiency<sup>[Ref]</sup></p><p>Adrenal insufficiency has been reported with opioid use, more often following greater than 1 month of use.  Androgen deficiency has occurred with chronic use of opioids.<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Urinary retention<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Visual disturbance</p>
<p><b>Frequency not reported</b>: Blurred vision</p>
<p><b>Postmarketing reports</b>: Miosis<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fatigue, chills</p>
<p><b>Uncommon</b> (0.1% to 1%): Shivering</p>
<p><b>Postmarketing reports</b>: Pyrexia<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Alfentanil Hydrochloride (alfentanil)." Akorn Inc, Buffalo Grove, IL. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about alfentanil</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>1 Review</li>
<li>Drug class: narcotic analgesics</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Advanced Reading</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Pain</li>
<li>Anesthesia</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to alfentanil: injectable solution</i></p><h3>General</h3><p>The most commonly reported adverse reactions include apnea, rigidity, and bradycardia.<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Apnea</p><p><b>Uncommon</b> (0.1% to 1%): Hypercarbia, laryngospasm</p><p><b>Frequency not reported</b>: Life-threatening respiratory depression, postoperative respiratory depression, bronchospasm, hypoxia, bradypnea, hiccups, hypercapnia, epistaxis, airway complication of anesthesia, endotracheal intubation complication </p><p><b>Postmarketing reports</b>: Respiratory arrest, cough<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Postmarketing reports</b>: Anaphylaxis<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Arrhythmia, bradycardia (14%), hypertension (18%), hypotension (18%), tachycardia (12%) </p><p><b>Frequency not reported</b>: Asystole</p><p><b>Postmarketing reports</b>: Cardiac arrest<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Chest wall rigidity (17%), </p><p><b>Common</b> (1% to 10%): Skeletal muscle movements, muscle rigidity</p><p><b>Uncommon</b> (0.1% to 1%): Skeletal muscle rigidity of neck and extremities<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Dizziness, movement disorders, dyskinesia</p><p><b>Uncommon</b> (0.1% to 1%): Headache</p><p><b>Frequency not reported</b>: Serotonin syndrome, seizures, sleepiness/postoperative sedation, somnolence, neurological anesthetic complication </p><p><b>Postmarketing reports</b>: Myoclonic movements<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Euphoric mood</p><p><b>Uncommon</b> (0.1% to 1%): Postoperative confusion, postoperative euphoria, excitation</p><p><b>Frequency not reported</b>: Addiction abuse, misuse, agitation, crying</p><p><b>Postmarketing reports</b>: Disorientation<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (28%), vomiting (18%)<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Itching, urticaria</p><p><b>Frequency not reported</b>: Pruritus, allergic dermatitis, hyperhidrosis</p><p><b>Postmarketing reports</b>: Erythema, rash<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Injection site pain<sup>[Ref]</sup></p><h3>Endocrine</h3><p>Opioids: </p><p><b>Postmarketing reports</b>: Adrenal insufficiency, androgen deficiency<sup>[Ref]</sup></p><p>Adrenal insufficiency has been reported with opioid use, more often following greater than 1 month of use.  Androgen deficiency has occurred with chronic use of opioids.<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Urinary retention<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Visual disturbance</p><p><b>Frequency not reported</b>: Blurred vision</p><p><b>Postmarketing reports</b>: Miosis<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fatigue, chills</p><p><b>Uncommon</b> (0.1% to 1%): Shivering</p><p><b>Postmarketing reports</b>: Pyrexia<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Alfentanil Hydrochloride (alfentanil)." Akorn Inc, Buffalo Grove, IL. </p><h2>More about alfentanil</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>1 Review</li>
<li>Drug class: narcotic analgesics</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Advanced Reading</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Pain</li>
<li>Anesthesia</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>